Method of using IL-11 for treating deficiencies in hematopoietic progenitor or stem cells
Patent Number: 6066317
Date of First Priority Issue: Wednesday November 22nd, 1989
Date Issued: Tuesday May 23rd, 2000
Assignee: Genetics Institute, Inc. (Cambridge, MA)
Inventors: Yang, Yu-Chung (Indianapolis, IN); Bennett, Frances K. (Melrose, MA); Paul, Stephan R. (Wyncote, PA)
From Class: Expansion
Comments: No comments
This patent teaches that interleukin 11 can be administered into patients for stimulation of hematopoietic activity. Interleukin 11 is known to upregulate platelet production but not as potently as TPO.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.